The CD4+ TIL subset was detected only in some of the patients (14/41; Figure 1B) and accounted for 1–30% of the leukocytes in the tumors (Figure 1A demonstrates a CD4-negative tumor biopsy and a CD4-positive biopsy). The gene discussed is CD4; the disease is neoplasm.